Location: Home
  • search
  • go
  • Relate News
  • 4/8/2025Tariffs Spark Market Jitters, But China's Innovative Drug Sector Remai...
  • 4/8/2025Asia-Pacific Vaccine Market Set for Steady Growth Through 2035 Despite...
  • 4/8/2025Duality Bio Upsizes IPO Amid Global Market Challenges
  • 4/8/2025CDE Solicits Comments on Draft Q&A for CMC Issues in rAAV-Based In Vi...
  • 4/8/2025Akeso Initiates Investigator-Initiated Trial for Personalized mRNA Vac...
  • 4/8/2025China Approves Hansoh's Ibrexafungerp for Vaginal Yeast Infections
  • 4/8/2025NIH Ban Disrupts Some Chinese Genetics Research, But Broader Impact Se...
  • 4/7/2025NMPA Solicits Comments on the Announcement on Matters Related to the I...
  • 4/7/2025NMPA Mandates Digital QR Code System for Drug Manufacturing Licenses
  • 4/7/2025China Receives 2.6 Million ADR Reports in 2024, Severe Cases Make Up 1...
  • 4/7/2025Boehringer Ingelheim Highlights Long-Term Commitment to China, Focuses...
  • 4/5/2025BeiGene Terminates Development of Ociperlimab Following Unfavorable Tr...
  • 4/5/2025Hansoh Initiates Phase 1 Trial for ADC Drug HS-20122 Targeting Advance...
  • 4/5/2025Sanofi and Cathay Capital Launch CNY 2B Healthcare Innovation Fund in ...
  • 4/5/2025Novartis' Fabhalta (iptacopan) Approved in China for C3 Glomerulopathy
  • 4/5/2025China and WHO Collaborate on Quality Management Training to Boost Vacc...
  • 4/5/2025Global Pharma Leaders Engage with President Xi Amidst U.S.-China Trade...
  • 4/5/2025CASI Pharma Evaluates CEO's $40M Proposal for China Operations
  • 4/5/2025Recent Executive Moves
  • 4/5/2025China Biopharma Licensing Tracker, Q1 2025 (MC)
  • 4/5/2025China Biopharma Financing Tracker, Q1 2025 (MC)
  • 4/5/2025Analysis of China-to-West Pharmaceutical Licensing Deals in 2024 (Natu...
  • 4/1/2025China's Pharma Industry Shows Signs of Recovery After Economic Downtur...
  • 4/1/2025China Accelerates Brain Chip Trials After Initial Success
  • 4/1/2025Akeso Eyes U.S. Approval for Innovative Lung Cancer Therapy
  • 4/1/2025Vivace Thera Raises $35M in Series D Financing
  • 4/1/2025Biotheus Initiates Phase 3 Trial for BNT327/PM8002 in China
  • 3/31/2025CDE Solicits Comments on the Draft Technical Specification of ICH M11:...
  • 3/31/2025Vcare PharmaTech Secures Series C+ Financing and Advances Clinical Pip...
  • 3/31/2025BMS's Opdivo and Yervoy Combio Approved in China
  • Page:31/789 Total number of articles:23668: [First][<<] [29] [30] [31] [32] [33] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group